Literature DB >> 15237450

Multidetector CT in evaluating blood supply of hepatocellular carcinoma after transcatheter arterial chemoembolization.

Yong-Song Guan1, Xiao-Hua Zheng, Xiang-Ping Zhou, Juan Huang, Long Sun, Xian Chen, Xiao Li, Qing He.   

Abstract

AIM: To assess the value of multidetector-row computed tomography (MDCT) in choosing retreatment methods of hepatocellular carcinoma (HCC) through evaluating the blood supply of low-density area of HCC after transcatheter arterial chemoembolization (TACE).
METHODS: Thirty-two patients with HCC after TACE treatment were examined by plain scanning and hepatic multidetector-row CT. The location of low-density area on plain scanning and the enhancement patterns on dynamic contrast-enhanced scanning were observed. At the same time, three-dimensional CT (3D CT) models of the volume rendering, curved multiplanar reformations, surface shaded display and maximum intensity projection reconstruction of the hepatic artery and portal vein were performed in 6 cases.
RESULTS: In CT plain scanning data, low density areas of 32 cases of HCC after TACE treatment were divided into three types: peripheral, one-side-located and mixed types. In contrast-enhanced CT scans, the blood supply of low-density area was classified into four types: arterial blood supply (20 cases), portal blood supply (5 cases), arterial combined with portal blood supply (5 cases) and poor blood supply (2 cases). In 6 cases, the relationship between the low-density area and branches of hepatic artery as well as portal vein was shown by 3D CT.
CONCLUSION: Hepatic MDCT is an effective method for evaluating the blood supply of low-density area and therapeutic effect of HCC after TACE treatment. Types of blood supply is helpful for the selection of retreatment.

Entities:  

Mesh:

Year:  2004        PMID: 15237450      PMCID: PMC4572349          DOI: 10.3748/wjg.v10.i14.2127

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Multi-detector row helical CT angiography of hepatic vessels: depiction with dual-arterial phase acquisition during single breath hold.

Authors:  Satoru Takahashi; Takamichi Murakami; Manabu Takamura; Tonsok Kim; Masatoshi Hori; Yoshifumi Narumi; Hironobu Nakamura; Masayuki Kudo
Journal:  Radiology       Date:  2002-01       Impact factor: 11.105

Review 2.  Current techniques of computed tomography. Helical CT, multidetector CT, and 3D reconstruction.

Authors:  Koenraad J Mortele; Jeffrey McTavish; Pablo R Ros
Journal:  Clin Liver Dis       Date:  2002-02       Impact factor: 6.126

3.  [Helical dual-phase CT scan in evaluating blood supply of primary heptocellular carcinoma after transcatheter hepatic artery chemoembolization with lipiodol].

Authors:  Li-lian Tan; Yang-bin Li; De-ji Chen; Shu-xin Li; Jin-dai Jiang; Zhi-ming Li
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2003-01

4.  Arterial chemoembolization for hepatocellular carcinoma.

Authors:  Jian Fan; Gao-Jing Ten; Shi-Cheng He; Jin-He Guo; Dong-Pei Yang; Guo-Ying Wang
Journal:  World J Gastroenterol       Date:  1998-02       Impact factor: 5.742

5.  [Evaluation of the efficacy of oil chemoembolization for hepatocellular carcinoma by computed tomography: a proposal for altering the criteria to indicate the efficacy].

Authors:  S Ikeya; K Takayasu; Y Muramatsu; N Moriyama; H Hasegawa; S Hirohashi
Journal:  Gan No Rinsho       Date:  1990-08

Review 6.  Diagnostic imaging and interventional therapy of hepatocellular carcinoma.

Authors:  L D Palma
Journal:  Br J Radiol       Date:  1998-08       Impact factor: 3.039

7.  Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence.

Authors:  R Murakami; S Yoshimatsu; Y Yamashita; K Sagara; A Arakawa; M Takahashi
Journal:  Acta Radiol       Date:  1994-11       Impact factor: 1.990

8.  Distribution of Lipiodol and evidence for tumor necrosis in hepatocellular carcinoma.

Authors:  M M Arnold; L Kreel; A C Wallace; A K Li
Journal:  Am J Clin Pathol       Date:  1992-03       Impact factor: 2.493

9.  Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion.

Authors:  Pamina Kim; Wijan Prapong; Daniel Y Sze; Samuel K So; Mahmood K Razavi
Journal:  Tech Vasc Interv Radiol       Date:  2002-09

10.  Palliative treatment of hepatocellular carcinoma by chemoembolization.

Authors:  A Poyanli; I Rozaneş; B Acunaş; S Sencer
Journal:  Acta Radiol       Date:  2001-11       Impact factor: 1.701

View more
  5 in total

1.  Confirmation of the posterior gastric artery using multi-detector row computed tomography.

Authors:  Takehiro Okabayashi; Michiya Kobayashi; Satoshi Morishita; Takeki Sugimoto; Toyokazu Akimori; Tsutomu Namikawa; Ken Okamoto; Norihiro Hokimoto; Keijiro Araki
Journal:  Gastric Cancer       Date:  2005       Impact factor: 7.370

Review 2.  [Modern CT and PET/CT imaging of the liver].

Authors:  J Klasen; T A Heusner; C Riegger; D Reichelt; J Kuhlemann; G Antoch; D Blondin
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

3.  Stereotactic Body Radiation Therapy as an Alternative to Transarterial Chemoembolization for Hepatocellular Carcinoma.

Authors:  Eli Sapir; Yebin Tao; Matthew J Schipper; Latifa Bazzi; Paula M Novelli; Pauline Devlin; Dawn Owen; Kyle C Cuneo; Theodore S Lawrence; Neehar D Parikh; Mary Feng
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-09-14       Impact factor: 7.038

4.  p53 gene (Gendicine) and embolisation overcame recurrent hepatocellular carcinoma.

Authors:  Y S Guan; Y Liu; X P Zhou; X Li; Q He; L Sun
Journal:  Gut       Date:  2005-05-05       Impact factor: 23.059

5.  Evaluation of extrahepatic collateral arteries in hepatocellular carcinoma in three independent groups in a single center.

Authors:  Yilin Zhao; Zhuting Fang; Jianjun Luo; Qingxin Liu; Gang Xu; Heng Pan; Wei Wei; Zhiping Yan
Journal:  Exp Ther Med       Date:  2015-10-22       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.